Financial Advocates Investment Management grew its position in shares of Global X U.S. Infrastructure Development ETF (BATS:PAVE – Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,382 shares of the company’s stock after purchasing an additional 11,853 shares during […]
Financial Advocates Investment Management decreased its holdings in First Trust Capital Strength ETF (NASDAQ:FTCS – Free Report) by 79.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,119 shares of the company’s stock after selling 190,914 shares during the period. Financial Advocates Investment […]
Financial Advocates Investment Management acquired a new position in shares of iShares MSCI USA Value Factor ETF (BATS:VLUE – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 35,671 shares of the company’s stock, valued at approximately $3,608,000. A number […]
Financial Advocates Investment Management raised its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,725 shares of the company’s stock after acquiring an additional 85 shares during the […]
Financial Advocates Investment Management lowered its position in Vanguard Total International Stock ETF (NASDAQ:VXUS – Free Report) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,601 shares of the company’s stock after selling 701 shares during the period. Financial Advocates Investment […]